Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.

Published in: Archives of gynecology and obstetrics (2018)

Long-term (60-month) treatment with dienogest 2 mg once-daily in women with endometriosis effectively reduced EAPP and avoided pain recurrence post-surgery. Dienogest was well tolerated and adverse effects were clinically managed.

Keyphrases

clinical practice
chronic pain
minimally invasive
physical activity
coronary artery disease
pain management
combination therapy
cross sectional
neuropathic pain
free survival
atrial fibrillation